Copper(I)‐Catalyzed Enantioselective Synthesis of Chiral Cyclohexenylallenes and Transfer of Axial to Center Chirality by Ytterbium (III) Catalyzed [4+2] Cycloaddition
Asian Journal of Organic Chemistry · 2024-05 · 13 (5)
DOI: 10.1002/ajoc.202300665 ↗Kurz gefasst
Fachartikel in der Zeitschrift Asian Journal of Organic Chemistry, online erschienen am 16.04.2024. Verfasst von Iddum Satyanarayana und 2 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 60 Literaturangaben.
Abstract (Originalsprache)
Chiral cyclohexenylallenes are readily accessed from 1‐enynes, aldehydes and chiral secondary amines in good yields (up to 79 % yield) with excellent enantioselectivities (up to 99 % ee), through CuI catalyzed the formation of chiral propargylamine intermediates. Subsequent Yb(OTf) 3 catalyzed [4+2] cycloaddition reaction of cyclohexylallenes with the dienophiles tetracyanoethylene and diethyl acetylenedicarboxylate afforded the corresponding bicyclic products in 69–75 % yield and 84–90 % ee.
Zitieren
APA
Satyanarayana, I., Mohan, L., & Periasamy, M. (2024). Copper(I)‐Catalyzed Enantioselective Synthesis of Chiral Cyclohexenylallenes and Transfer of Axial to Center Chirality by Ytterbium (III) Catalyzed [4+2] Cycloaddition. Asian Journal of Organic Chemistry, 13(5). https://doi.org/10.1002/ajoc.202300665
Vancouver
Satyanarayana I, Mohan L, Periasamy M. Copper(I)‐Catalyzed Enantioselective Synthesis of Chiral Cyclohexenylallenes and Transfer of Axial to Center Chirality by Ytterbium (III) Catalyzed [4+2] Cycloaddition. Asian Journal of Organic Chemistry. 2024;13(5). doi:10.1002/ajoc.202300665
BibTeX
@article{Satyanarayana2024,
author = {Satyanarayana, Iddum and Mohan, Lakavathu and Periasamy, Mariappan},
title = {Copper(I)‐Catalyzed Enantioselective Synthesis of Chiral Cyclohexenylallenes and Transfer of Axial to Center Chirality by Ytterbium (III) Catalyzed [4+2] Cycloaddition},
journal = {Asian Journal of Organic Chemistry},
year = {2024},
volume = {13},
number = {5},
doi = {10.1002/ajoc.202300665}
}
EUVIMED